XpresTest

Overview

XWELL-linked biosecurity subsidiary with prior U.S. airport disease-screening work and 2026 CDC and State Department awards totaling about $38.8 million in reported face value.

Connects publicly documented federal public-health procurements and assistance awards to a financed parent company.

Disease-screening operations

XpresTest has performed traveler screening and surveillance at U.S. airports, including earlier COVID-19-related work.

2026 federal work

ProPublica reported an approximately $18.8 million CDC Ebola entry-screening contract and a separate $20 million State Department infectious-disease response award for the Democratic Republic of Congo. XWELL's proxy describes an initial CDC contract term of up to $18.1 million with an optional extension, which need not equal the full reported award value.

Experience and delivery uncertainty

The company had domestic traveler-screening experience. Its CEO acknowledged international disease-response work was new to the business. Reported award amounts are not amounts paid or proof of completed services.

Ownership and divestiture

XWELL agreed in July 2026 to sell the subsidiary, subject to conditions. An October 28 shareholder vote approved the proposal; the sale closing was not independently verified as of November 9.

Documented relationships

• XWELL

  Parent/subsidiary relationship at the time of 2026 federal awards; proposed sale remained subject to conditions · 2026 · Evidence (documented)

• Centers for Disease Control and Prevention

  CDC Ebola entry-screening contract reported at about $18.8 million; proxy describes an initial term of up to $18.1 million plus possible extension · 2026 · Evidence (reported)

• U.S. Department of State

  State Department infectious-disease outbreak-response award for Democratic Republic of Congo reported at $20 million · 2026 · Evidence (reported)

A documented investment, family relationship or federal award does not establish undue influence or illegal conduct. Reported award ceilings are not the same as money paid.

Focused relationship map

View the full interactive relationship map

Related entries

• XWELL
• American Ventures
• Centers for Disease Control and Prevention
• U.S. Department of State

Sources

1. ProPublica — 2026 Ebola and disease-surveillance awards
2. XWELL proxy — CDC contract terms and divestiture
3. XWELL shareholder vote on proposed divestiture

Source status: SEC filings and organizational records establish the transactions and affiliations described; ProPublica independently reports the federal awards and attributed responses. Where original award files have not been obtained, claims remain attributed.